Press Release
PAI Pharma Acquires Nivagen Pharmaceuticals, Expanding Domestic Sterile Injectable Manufacturing and Ready-To-Use Product Offering in the Hospital Market
PAI Pharma Acquires Nivagen Pharmaceuticals
PAI Pharma Acquires Nivagen Pharmaceuticals
Olympus Partners has acquired PAI Pharma
In response to FDA ban of Red No.3, PAI Pharma shares more than 60 products in the portfolio are dye-free.
PAI Pharma is pleased to announce the acquisition of VistaPharm—a privately held, healthcare company that offers generic pharmaceuticals and over the counter products for hospitals, retail pharmacies, and the specialized clinical setting.